Four conditional responses (CRs) were measured in rats implanted with bilateral cannulas in the basolateral nuclear complex of the amygdala (BLA). During retention testing in either the original training context or a shifted context, BLA was infused with artificial cerebral spinal fluid (ACSF) or ACSF containing an N-methyl-D-aspartate receptor antagonist (APV). Regardless of the testing context, APV infusion into BLA completely blocked the expression of conditional eyeblink facilitation and significantly attenuated the expression of conditional freezing, ultrasonic vocalization, and defecation. Discriminant analysis found eyeblink facilitation to be comparable to freezing in predicting group membership (APV vs. ACSF) and both to be better predictors than the other two CRs. The APV effect did not depend on the exact cannula positions within BLA.
After being paired with an aversive unconditional stimulus (US), a previously neutral conditional stimulus (CS) may elicit various types of conditional fear responses (CRs), including defensive behaviors (freezing, 22-kHz ultrasonic vocalization [USV] ), autonomic reactions (changes in heart rate, blood pressure, urination or defecation), altered pain sensitivity (analgesia), and reflex facilitation (trisynaptic eyeblink reflex or whole-body acoustic startle response). Fear-related CRs are thought to be created by converging CS-and US-generated synaptic activity in the basolateral nuclear complex (BLA) of the amygdala (Blair, Schafe, Bauer, Rodrigues, & LeDoux, 2001 ; T. H. Fanselow & LeDoux, 1999; Lavond, Kim, & Thompson, 1993; LeDoux, 2000; Rogan, Staubli, & LeDoux, 1997) . For 3 decades, associative long-term potentiation (LTP) has been the leading candidate synaptic mechanism for creating new CS-CR connections as a function of converging CSand US-generated postsynaptic activity (Barrionuevo & Brown, 1983; T. H. Brown, Chapman, Kairiss, & Keenan, 1988; Kelso, Ganong, & Brown, 1986; Levy, 1985; Levy & Steward, 1983) .
In some synapses, the induction of associative LTP critically depends on glutamate binding to N-methyl-D-aspartate receptors (NMDARs) on the postsynaptic neuron (T. H. . It is therefore interesting that intra-BLA infusion with the NMDAR antagonist, DL-2-amino-5-phosphovaleric acid (APV), consistently blocks the acquisition of fear CRs (Campeau, Miserendino, & Davis, 1992; Fanselow & Kim, 1994; Gewirtz & Davis, 1997; Lee & Kim, 1998; Maren, Aharonov, Stote, & Fanselow, 1996; Miserendino, Sananes, Melia, & Davis, 1990) . These behavioral experiments are consistent with the idea that the induction of an NMDAR-dependent form of associative LTP plays a key role in creating new CS-CR connections. To place this fact in context, it is important to note that an NMDAR-independent form of associative LTP (Cavus & Teyler, 1996; Johnston, Williams, Jaffe, & Gray, 1992; Teyler, 2000) has also been reported in the amygdala (Bauer, Schafe, & LeDoux, 2002; Weisskopf, Bauer, & LeDoux, 1999 ) and hypothesized to participate in conditioning (Blair et al., 2001 ; T. H. . The induction of NMDAR-independent associative LTP is blocked by antagonists of L-type Ca 2ϩ channels, but not by APV (Bauer et al., 2002; Cavus & Teyler, 1996; Kapur, Yeckel, Gray, & Johnston, 1998) .
The evidence is conflicting regarding the effects of APV infusion on the expression of previously-acquired CRs. The first set of studies (Campeau et al., 1992; Gewirtz & Davis, 1997; Miserendino et al., 1990) reported that infusing APV into BLA just before testing had absolutely no effect on CR expression. One inference from these studies-that NMDARs in BLA are required for CR acquisition but are not required for expressing previously acquired CRs-was suggested to parallel the neuropharmacology of LTP induction and expression in the amygdala (Davis, 1993; Davis, Rainnie, & Cassel, 1994) . Results from the behavioral pharmacology were offered as evidence that NMDARs participate in learning-related LTP induction but are not required to maintain "general levels of cell excitability in the amygdala" (Gewirtz & Davis, 1997, p. 472) .
LTP is known to occur in BLA (Bauer et al., 2002; Chapman, Kairiss, Keenan, & Brown, 1990; Clugnet & LeDoux, 1990; Doyere, Schafe, Sigurdsson, & LeDoux, 2003; Maren & Fanselow, 1995; Rogan et al., 1997; Rogan & LeDoux, 1995; Shindou, Watanabe, Yamamoto, & Nakanishi, 1993) , but concentrations of APV that block its induction are reported also to impair synaptic transmission (Chapman & Bellavance, 1992) . As in other circuits (Armstrong-James, Welker, & Callahan, 1993; Binns, 1994) , the function of NMDARs in BLA appears not to be limited to LTP induction but also includes aspects of postsynaptic signaling (Li, Phillips, & LeDoux, 1995; Li, Stutzmann, & LeDoux, 1996; Maren & Fanselow, 1995; reviewed in T. H. Brown et al., 2003) . If CR acquisition and expression are supported, respectively, by the induction and expression of associative LTP, then these initial behavioral studies (Campeau et al., 1992; Gewirtz & Davis, 1997; Miserendino et al., 1990) seem to be at odds with the synaptic neuropharmacology.
Although this laboratory and others have published neurophysiological recordings showing that APV can block the induction of associative LTP without seeming to affect its expression (see Figure 16 in T. H. Brown, Ganong, Kairiss, Keenan, & Kelso, 1989) , the essential experimental condition for this outcome is that the postsynaptic neuron be sufficiently hyperpolarized during testing to eliminate any substantial APV-sensitive component of the measured postsynaptic currents. Postsynaptic signals that bring the membrane potential near its firing threshold are naturally expected to evoke NMDA currents (Kotecha & MacDonald, 2003; Nakanishi et al., 1998) , in which case blocking them should have some affect on overall circuit function. The theoretical expectation is that the expression of associative LTP, through suprathreshold neural activity in the circuits that enable the acquired CS-CR pathways, should be affected by blocking the NMDAR-associated component of the postsynaptic currents. This expectation is unchanged if the induction of an NMDAR-independent form of associative LTP is instead assumed to be responsible for the acquired CS-CR connections.
More recent behavioral analyses have consistently reported that APV infusion protocols that block CR acquisition also impair CR expression (Fendt, 2001; Lee & Kim, 1998; Lee, Choi, Brown, & Kim, 2001; Maren et al., 1996) . Among the studies that did find a significant APV effect on CR expression, the effect size seemed to be large and consistent across multiple CRs, suggesting that the apparent contradictions in the literature are not beta errors associated with a subtle and variable drug action. Understanding the source of these differences is critically important because it bears on current efforts to create an internally consistent neurophysiological understanding of emotional learning and memory (T. H. Davis, 1997; Fendt & Fanselow, 1999; Izquierdo & McGaugh, 2000; LeDoux, 2000; Maren, 2001 ).
The present experiments were designed to evaluate four hypotheses about the source of these discrepant reports. The first hypothesis, proposed by coworkers (1998, 2001) , maintains that the effect of APV infusion is CR specific. They note that the studies that found APV infusion to have no effect on CR expression (Campeau et al., 1992; Gewirtz & Davis, 1997; Miserendino et al., 1990 ) used a variant of the conditional reflex facilitation procedure developed by J. S. Brown, Kalish, and Farber (1951) . The CR in these studies is the magnitude of CS-produced facilitation of the acoustic startle response.
On the other hand, the CRs whose expression is consistently found to be APV sensitive include conditional freezing, 22-kHz USV, defecation, and analgesia (Lee et al., 2001; Lee & Kim, 1998; Maren et al., 1996) . There is an obvious temporal difference between these APV-sensitive CRs and conditional reflex facilitation. The former can persist long after the termination of the CS, whereas conditional reflex facilitation appears to be timed to correspond to the CS-US interstimulus interval (ISI; Davis, Schlesinger, & Sorenson, 1989; Lindquist & Brown, in press ). Too little is known about the neurophysiology of the critical CS-CR circuits to rule out the possibility that timed CRs are less disrupted by APV infusion than untimed ones.
Here we examine the effect of APV infusion on the expression of conditional reflex facilitation and three other CRs (conditional freezing, USV, and defecation) that have been consistently shown to be APV sensitive. Instead of assessing CS effects on the whole-body, acoustic startle response to an aversively loud noise, as in the original experiments by J. S. Brown and coworkers (1951) , we decided instead to measure CS-produced facilitation of the R1 electromyographic (EMG) component of the eyeblink reflex (Choi, Lindquist, & Brown, 2001b; Lam, Wong, Canli, & Brown, 1996; Lindquist & Brown, in press ). The trisynaptic R1 reflex is simpler, better understood, and easier to interpret, both within and among species Choi et al., 2001b; Evinger, Shaw, Peck, Manning, & Baker, 1984; Faulkner, Brown, & Evinger, 1997; Lam et al., 1996; Lindquist & Brown, in press; Manning & Evinger, 1986; Pellegrini, Horn, & Evinger, 1995) . In this first comparison of conditional R1 facilitation with freezing, USV, and defecation, we also describe the CR correlation matrix and then use discriminant analysis to evaluate their relative sensitivities, singly and in combination, to APV infusion into BLA.
The second hypothesis, suggested by Fendt (2001) , concerns the testing context. Fendt (2001) noted that his own experiment on conditional facilitation of the acoustic startle response, which did find a significant APV infusion effect, tested retention in a different context from that used in conditioning. This is also true of the other studies that found a significant APV effect on CS-dependent CR expression (Lee et al., 2001; Lee & Kim, 1998) . Conversely, all of the studies that report no APV effect on CR expression tested retention in the original conditioning chamber (Campeau et al., 1992; Gewirtz & Davis, 1997; Miserendino et al., 1990) . If context and cue conditioning summate nonlinearly, then CR expression could theoretically be less sensitive to APV when testing is done in the original training context. To evaluate this theoretical possibility, we administered retention testing, in separate experiments, either in the original conditioning chamber (Experiment 1B) or in a shifted context (Experiment 1A).
The third hypothesis, an alternative proposal by Fendt (2001) , is that the apparent contradictions between studies reflect the precise location of the tips of the cannulas within BLA. The study by Fendt (2001) , which did report a significant APV infusion effect, targeted the cannulas at the lateral subnucleus of the amygdala (LA), whereas the earlier studies that failed to see an APV effect (Campeau et al., 1992; Gewirtz & Davis, 1997; Miserendino et al., 1990) targeted the basolateral subnucleus (BL). We therefore looked for evidence in support of Fendt's alternative hypothesis by analyzing the results from APV-infused rats as a function of whether the cannulas were located bilaterally in or dorsal to LA or BL.
The fourth hypothesis, suggested by Choi and coworkers (Choi et al., 2001a (Choi et al., , 2001b , concerns the fact that the acoustic startle response rapidly habituates (Davis, 1972; Davis & Wagner, 1969; Koch, 1999; Leaton, Cassella, & Borszcz, 1985) . This problem, which is sometimes addressed by habituating rats to the startle stimulus prior to the start of a test session (Campeau et al., 1992; Fendt, 2001; Gewirtz & Davis, 1997; Miserendino et al., 1990) , can complicate the interpretation of subsequent increases in levels of responding and, in conjunction with other factors, has been argued to be another possible source of conflicting results (Choi et al., 2001a (Choi et al., , 2001b .
One of the reasons for selecting the R1 reflex for these studies Choi et al., 2001b; Lam et al., 1996; Lindquist & Brown, in press) was the claim that it does not habituate or easily fatigue (Basso, Strecker, & Evinger, 1993) . However the stability of this reflex has never been evaluated under precisely the same experimental conditions that were used during retention testing. To furnish a reasonable basis for comparison, R1 stability was therefore examined in the conditioning chamber, at the usual test rate, before and after each rat was fear conditioned in the normal manner. Linear regression was used to evaluate the stability of the R1 amplitudes across trials.
Method

Experiment 1A
The purpose of this experiment was to determine whether conditional reflex facilitation, unlike freezing, USV, or defecation, is insensitive to APV infusion into BLA. Conditioning to a tone CS was tested in a context different from that in which training occurred. The context shift was intended to make the results more comparable to our previous comparisons (Lee et al., 2001 ) of APV infusion effects on CR expression and to minimize interactions between cue and context conditioning, which could differ among CRs. On the 1st day of testing, BLA was infused with either artificial cerebral spinal fluid (ACSF) or APV dissolved in ACSF. A 2nd day of identical testing was done without BLA infusion to reveal CR production in the absence of any experimental perturbation of amygdalar function.
Subjects. Forty-three experimentally naive male Sprague-Dawley rats (Charles River, Kingston, NY) were used in Experiment 1A. Each rat was housed individually, with ad-lib access to food and water, and kept in a vivarium with a 12-hr light-dark cycle. Rats were handled at least 2 days (3-5 min/day) before surgery. At the time of surgery, subjects weighed between 200 and 260 g. All of the following procedures, including surgery and postoperative care, were in strict compliance with the Yale Animal Resource Center guidelines.
Surgery. Subjects were anesthetized with an intraperitoneal injection of Ketamine (90 mg/kg) and Xylazine (10 mg/kg). A petroleum-based ophthalmic ointment was applied to both eyes to prevent the cornea from drying out. Throughout the surgery, rats were kept on a heating pad (Braintree Scientific, Braintree, MA) to maintain body temperature. All surgical procedures were performed under aseptic conditions. Twenty-sixgauge guide cannulas (C315G, Plastics One, Roanoke, VA) were bilaterally implanted into BLA by using a stereotaxic instrument. Coordinates, relative to bregma, were as follows: AP Ϫ2.3, ML 5.0, and DV Ϫ7.7. Four stainless steel screws were fastened to the rat's skull for anchoring guide cannulas with dental acrylic. Dummy cannulas (C315DC, Plastics One), cut 0.5 mm longer than the guide cannulas, were inserted into the guide cannulas upon completion of the surgery.
The nerve cuff used to elicit the R1 response was made of a short piece of longitudinally split PE-50 tubing (roughly 2 mm) and two Teflon-coated stainless steel wires (0.0055 in. [0.140 mm] coated; 0.003 in. [0.076 mm] bare; A-M Systems, Everett, WA). Teflon was removed from the portion of the wires inside the nerve cuff for stimulating the nerve. During surgery, the nerve cuff was placed around the supraorbital (SO) branch of the fifth nerve and secured in place with a piece of silk suture. The SO was cuffed unilaterally. Teflon-coated wires were used for recording EMG activity in the orbicularis oculi (OO) muscle surrounding the eye. The tip of each wire, exposed ϳ2 mm at the tip and bent into a V-shape, was implanted into the OO muscle in the nasal and medial regions of the eye. The nerve cuff, EMG electrodes, and a bare ground wire, inserted underneath the skin in the back of the neck, were all connected to a 5-pin male amphenol connector. The headset was situated between the two guide cannulas and cemented onto the four screws on top of the skull. The headset could then be electrically connected to the amplifier and recording equipment during conditioning and testing.
Apparatus. Two conditioning chambers were used in all conditioning and testing sessions. Each conditioning chamber had a standard grid floor consisting of parallel steel rods (5 mm diameter and 15 mm spacing) with interior dimensions of 22 cm long ϫ 28 cm wide ϫ 42 cm high (modified from Model ENV-001; MED Associates, Fairfield, VT). The headset of each subject was attached to a commutator (CAY-675-12; Airflyte, Bayonne, NJ) at the top of each conditioning chamber. The chambers were equipped with an infrared light source and video camera (CB-21; Circuit Specialists, Mesa, AZ) to observe and record the rat's behavior during the experiment. Each chamber also contained a heterodyne bat detector (Mini-2 and Mini-3; Noldus Information Technology, Wageningen, the Netherlands) to transform high-frequency (22 Ϯ 5 kHz) USVs into the audible frequency range. The audio and video signals from each chamber were fed to video recorders for offline analysis. The conditioning chambers were housed in one of two different sound-attenuating cubicles.
The first cubicle was made of melamine lined with foam insulation and had exterior dimensions of 64 cm long ϫ 38 cm wide ϫ 59 cm high (ENV-018S; MED Associates). The second cubicle was made of white PVC insulated with Styrofoam and had exterior dimensions of 64 cm long ϫ 38 cm wide ϫ 63 cm high (ENV-018XX; MED Associates). Within each sound-attenuating cubicle, a ventilation fan gave a constant background noise of 65 dB. The insides of the cubicles were not illuminated (0 lux) in the visible spectrum. The tone CS (3.7 s, 4 kHz, 75 dB) was delivered by a speaker mounted on the side of each chamber. The coterminating, grid-shock US (500 ms, 0.6 mA) was produced by a small animal shock generator (E13-14; Coulbourn Instruments, Allentown, PA). The root mean square (RMS) current was measured conventionally (Choi et al., 2001b; Lindquist & Brown, in press) from the voltage across the smaller of two resistors (1 k⍀ and 100 k⍀) connected in series between adjacent grid bars.
Electrical stimulation and recording. Procedures for eliciting and measuring the R1 EMG response were based on those of Evinger and coworkers Pellegrini et al., 1995) . The EMG, produced by direct SO stimulation, is recorded in the OO muscle, which is responsible for generating the active downward force during a reflex blink (Manning & Evinger, 1986) . The SO-produced EMG response contains an early (R1) and late (R2) component. The circuit responsible for the R1 response can be traversed with just three sets of neurons: from the fifth trigeminal nerve to the fifth nucleus (spinal trigeminal nucleus; SpV), from the fifth nucleus to the seventh nucleus (facial motor nucleus; FMN), and from the seventh nucleus to the OO muscle Hiraoka & Shimamura, 1977; Pellegrini et al., 1995) .
Nerve cuff stimulation (NCS) and EMG recording methods were similar to those described previously Choi et al., 2001b; Lam et al., 1996; Lindquist & Brown, in press ). The SO was stimulated by a single biphasic pulse (0.2 ms first part, 0.1 ms second part) generated by a programmable pulse generator (Master-8; A.M.P.I., Jerusalem, Israel). The biphasic pulse was delivered through a stimulus isolation unit (Model BSI-2; Bak Electronics, Germantown, MD). The SO stimulating current was adjusted for each rat to a level that produced consistent R1 responses (defined below). The current required to do so ranged from 0.035 to 2.000 mA. The large range, also observed in previous studies, most likely results from the highly idiosyncratic branching pattern of the fifth nerve, the precise location of the nerve cuff, the diameter of the nerve at the site of the cuff, or the fit of the cuff to the nerve. The output from the two EMG electrodes was connected to a differential AC amplifier (Model 1700, A-M Systems, Carlsborg, WA). The EMG response was amplified (1000ϫ) and bandpass filtered (0.3 kHz and 5 kHz, 4-pole Bessel filter, 40 dB/decade) before being digitized at a sampling rate of 10 kHz. Presentation of stimuli and sampling and storage of EMG responses were controlled by means of a multifunction data acquisition system (Datawave Technologies Corp., Longmont, CO).
Cannula care and microinfusion. One to 2 days before the start of the experiment, all rats were brought into the conditioning/testing room and allowed to move about in a plastic chamber (30 cm long ϫ 19 cm wide ϫ 10 cm high) for approximately 2 min before having their dummy cannulas removed and replaced with clean cannulas. All rats were adapted (prior to testing) in this way to the cannula-removal procedure and to the chamber in which infusions occurred. On the 1st day of testing, all rats had their dummy cannulas removed and replaced with 33-gauge internal cannulas (C315I; Plastics One). The internal cannulas, which extended roughly 1 mm beyond the guide cannulas, were connected to 10-l Hamilton syringes (Reno, NV) via PE-20 polyethylene tubing. The tubing was backfilled with distilled H 2 0, with a small air bubble separating the water from the drug solution. APV (Sigma-Aldrich, St. Louis, MO; 4.2 g/side), dissolved in ACSF (pH 7.4), was bilaterally infused (0.5 l total volume per side, each at a rate of 0.2 l/min) into the BLA with a syringe pump (PHD 2000; Harvard Apparatus, Cambridge, MA). Control rats were infused (0.5 l total volume per side, each at 0.2 l/min) with ACSF alone. After infusion, cannulas were left in place another 30 s to ensure proper drug dispersal before the rat was placed into the testing chamber. Once testing was complete, the dummy cannulas were replaced, and the rat was returned to its home cage.
Experimental design and statistical analysis. Experiment 1A used a mixed 2 ϫ 2 design, with drug (APV vs. ACSF) as the between-subjects factor and test day (Test Day 1 vs. Test Day 2) as the within-subjects factor. Before conditioning, each rat was pseudorandomly assigned to either the APV (experimental) or ACSF (control) group. All rats experienced 1 day of habituation to the conditioning context, 3 days of fear conditioning, and 2 days of CS-alone testing (extinction trials). Each subject was habituated and trained in one of the two chambers and then switched to the alternate chamber on both test days. The chamber used for training was randomized. The context shift during testing was intended to reduce the influence of contextual conditioning, which could, in principle, introduce a ceiling effect on cue conditioning.
Habituation, conditioning, and testing. Seven to 10 days following surgery, subjects were habituated for 40 min in one of the two conditioning chambers. Each chamber was cleaned using a vinegar-and-water (1:3) solution or Windex immediately prior to the rat being placed inside the chamber. At the end of the habituation session, the R1 response quality was evaluated. The NCS current was initially set at 0.4 mA and then increased or decreased as needed. The R1 response was deemed satisfactory for further use if the NCS-produced stimulus artifact (SA) did not contaminate (temporally overlap) the R1 onset and the R1 onset latency was between 4 and 10 ms from the SA onset (see Figure 1) . A subject that did not meet these requirements on the habituation day, or any of the following 3 conditioning days, was dropped from the study.
One day after habituation, the 1st of 3 days of conditioning began. Each day, immediately before training, the quality of a rat's R1 response was evaluated, with adjustments to NCS intensity made as needed. Note that NCS was not part of the conditioning procedure. All subjects received 10 pairings of the 3.7-s tone CS and the coterminating 0.5-s US for 3 consecutive days (3.2 s ISI). The intertrial interval (ITI) was chosen from a preselected uniform distribution (30 s bins) ranging from 180 to 300 s (mean of 240 s). An explicitly unpaired control group was not required because we have previously demonstrated that rats trained with unpaired CS-US presentations do not show R1 facilitation to the tone CS (Choi et al., 2001b; Lam et al., 1996) .
Following 3 days of conditioning, each rat received 2 consecutive days of testing. Each rat was tested in a chamber made to differ in three respects from the one in which it was trained. First, during testing, the grid bars in each chamber were covered with a sheet of Plexiglas angled 5°from horizontal. Second, the two chambers were cleaned with different solutions (a vinegar-and-water solution or Windex) immediately before the rat was placed inside. Third, the walls of the two chambers were different-one having a black criss-cross pattern over the Plexiglas.
Testing consisted of eight NCS ϩ tone trials and eight NCS-alone trials. NCS ϩ tone trials occurred 3.2 s after tone onset, corresponding to the training ISI. These two trial types were presented in a pseudorandom order such that neither trial type occurred consecutively more than twice in a row. The ITI during the testing session was pseudorandomly chosen from a uniform distribution ranging from 25 to 35 s (empirical mean of 30 s). The testing ITI was shortened, relative to that used for conditioning (240 s), to ensure that the entire test session could be completed while APV remained effective. On Test Day 1, each rat was infused with either APV or ACSF; neither group of rats was infused on Test Day 2. After each rat was placed into the testing chamber, the R1 response was quickly reexamined to ensure its usability. The current used to elicit the R1 response Figure 1 . R1 responses elicited by nerve-cuff stimulation (NCS) in 2 representative rats. Each trace is the average of eight rectified electromyograph responses recorded from the orbicularis oculi muscle. The short vertical lines below each trace indicate the limits of the integration window used to calculate the area of each response. A: R1 responses from a rat that was infused with DL-2-amino-5-phosphovaleric acid (APV). The amount of R1 facilitation is the difference between the R1 area in the presence (top trace) and absence (bottom trace) of the cue. APV completely blocked conditional stimulus-produced R1 facilitation. B: R1 responses in a rat that was infused with artificial cerebral spinal fluid (ACSF). R1 facilitation is clearly evident in the upper (NCS ϩ tone) trace. The cerebellum-dependent R2 response, which is occasionally seen, is marked by an asterisk. SA ϭ stimulus artifact; Tone ϭ conditional stimulus. was kept constant across both days of testing. The testing session began after a brief acclimation period (ϳ30 s) that itself started ϳ40 s from the end of the BLA infusion (ϳ30 s for drug dispersal plus ϳ10 s to place rat into the conditioning chamber and check R1 response). At the end of the testing session, rats were removed from the chamber, their guide cannulas were reinserted, and they were returned to their home cages. All test sessions were recorded for offline analysis of freezing and 22-kHz USV.
A design constraint was to complete testing within ϳ10 min of the end of BLA infusion (cf. Lee et al., 2001 ), on the presumption that behavioral effects observed at much longer latencies may be more likely to reflect the consequence of lower drug concentrations acting on a larger-than-intended volume of tissue. Our experience with infusing various types of NMDAR antagonists into BLA suggests that the behavioral effects persist throughout the entire 8-min testing period (ϳ550 s from the end of infusion). Nothing is known about the time course of changes in the spatial concentration gradients of APV following BLA infusion or the time course of behavioral effects at much longer infusion latencies. These time constraints did not allow measurement of a stable pre-CS level of freezing, USV, and defecation. In the case of these three CRs, no distinction can therefore be made in terms of the relative contributions of cue versus context conditioning (but see Lee & Kim, 1998) , both of which have previously been shown to be impaired by BLA infusion with APV during retention testing (Lee et al., 2001 ). In the case of R1 facilitation, by contrast, cue-specific conditioning was measured from differences between the NCS ϩ tone trials and intermixed NCS-alone trials. It is known that the levels of freezing and USV are negligible in the test apparatus in the absence of conditioning (Choi & Brown, 2003) .
R1 response analysis. The EMG data were analyzed with BLINK, a custom program written in C (Choi, 2000) . BLINK displayed the raw EMG waveform on individual trials, computed the baseline noise level, rectified the EMG waveform, detected the onset and offset of the R1 component of the EMG, and calculated the area under the waveform (Figure 1 ). The automatic determination of the onset and offset of each R1 response was visually displayed and double-checked by the experimenter. Although BLINK and the experimenter usually agreed on the placement of the integration window, in some cases (Յ 10%) the onset or offset times required manual correction. Program errors usually occurred on the first of the eight test trials and typically required that the onset of the integration window be shifted later in time. Once corrected on the first trial, no further adjustments were required or made. The NCS current level that is just sufficient to produce a reliable R1 response in the rat generally produces many fewer and much smaller R2 responses (asterisk in Figure 1 ). The baseline EMG noise level was defined as the RMS of the 10 ms interval prior to the SA. Traces with an RMS noise level (calculated on the nonrectified EMG) that exceeded 50 V were discarded, resulting in a rejection rate of 1.7% (15 out of 896 trials).
CS-produced changes in the R1 response were assessed conventionally, based on a percentage measure (F) of conditional R1 facilitation for each rat (Choi et al., 2001b; Lam et al., 1996; press):
where n is the number of trials (usually 8 in these experiments) over which the R1 areas are summed. Analysis of defecation, freezing, and USV. At the end of each test session, the total number of fecal boli in each chamber was counted. Video and audio recordings of each test session were used for offline analysis. Freezing and USV were measured, using a time-sampling procedure, by a blind and naive assistant. Freezing, an established index of conditioned fear in the rat, was defined as cessation of all movement except that required for respiration (Fanselow, 1997) . Each video recording began simultaneously with the test session, which started ϳ30 s after the rat was placed into the conditioning chamber. Starting at the beginning of each video recording, a 500-ms tone was emitted every 4 s. In reviewing these recordings, an assistant decided whether the rat was freezing during each tone. The assistant's scores were then compared with those of the experimenter, who independently evaluated a subset of the same data. The interobserver reliability was almost perfect (Pearson's r ϭ .97). Freezing scores are presented as percentages, calculated by dividing the number of instances of freezing by the total number possible (15 per min, or 120 in an 8-min test session). USVs were scored in the same way. With each tone (every 4 s) the observer determined whether the rat was emitting a 22-kHz USV. USV scores were similarly calculated as percentages. Again, the interobserver reliability was almost perfect (r ϭ .99).
Histology. After completing behavioral testing, the rats were deeply anesthetized with Nembutal followed by Halothane. They were perfused with physiologically buffered saline followed by a 10% Formalin solution. The brain was removed from the skull and stored in 10% Formalin for a minimum of 24 hr, followed by storage in a 30% sucrose solution for 3-4 days. The brain was coronally sectioned at 60 m with a freezing-stage microtome and mounted on gelatin-coated slides. Sections were stained with Nissl stain (thionine). Microscopic examination of each section (Zeiss Axioskop, 2.5 ϫ objective, Carl Zeiss Microimaging, Thornwood, NY) identified the most ventral position of each cannula track, which was then drawn, using a camera lucida, onto anatomically matched sections from the brain atlas of Paxinos and Watson (1998) . Photomicrographs of selected sections (see Figure 2C) were taken using the Zeiss Axiophot module.
Experiment 1B
The purpose was to determine whether CR expression becomes APV insensitive when testing is done in the original training context. All procedures and analysis were identical to those in Experiment 1A except the location of cue testing.
Subjects, surgeries, and behavioral testing. Two groups of SpragueDawley male rats (200 -265 g at time of surgery) underwent the same surgical procedure outlined in Experiment 1A. The current required to elicit an R1 response ranged from 0.15 to 3.5 mA. Seven of 832 trials (0.8%) were dropped because the RMS noise level, during the 10-ms baseline, exceeded 50 V. Except for the test location, the behavioral procedures were identical to those used in Experiment 1A. Rats received 1 day of habituation, 3 days of conditioning, and 2 days of testing. Habituation, conditioning, and testing all occurred in the same chamber. Conditioning consisted of 10 tone-shock pairings with a 240 Ϯ 60-s ITI. On the 1st test day, each subject was bilaterally infused with 0.5 l APV or ACSF prior to the 8-min test session. On the 2nd test day, neither group of rats was infused before testing.
Experimental design and statistical analysis. Experiment 1B used a mixed 2 ϫ 2 design (as in Experiment 1), with drug (APV vs. ACSF) as the between-subjects factor and test day (Test Day 1 vs. Test Day 2) as the within-subjects factor. The only procedural change from Experiment 1A was that cue testing was performed in the training context. The statistical analysis was identical.
Experiments 1A and 1B
Pooled data. After the two data sets were compared, the results were pooled to increase the sample size for three purposes: to describe the correlation matrix for these four CRs, which have not been studied together before; to compare the relative sensitivities of the different CRs to disruption by intra-BLA APV infusion; and to evaluate whether a critical difference between studies that do and do not report an APV infusion effect might be the exact location of the cannula tip within BLA.
Experimental design and statistical analysis. Statistical analyses of pooled data from Experiments 1A and 1B used a mixed 2 ϫ 2 design (as in Experiments 1A and 1B), with drug (APV vs. ACSF) as the betweensubjects factor and test day (Test Day 1 vs. Test Day 2) as the withinsubjects factor. Further statistical analyses used a 2 ϫ 3 design, with drug (APV vs. ACSF) and infusion site (lateral, basolateral, or mixed; defined below) as between-subject factors.
Experiment 2
The purpose was to determine whether the R1 response is stable under the same conditions that were used during retention testing. Ten NCS-alone trials (30-s ITI) were evaluated in each rat before and after 3 days of fear conditioning, as in the first experiment.
Subjects, surgeries, and behavioral testing. Sprague-Dawley male rats (195-260 g) received the previously described surgery for studying R1 neurophysiology, but none were cannulated. Testing consisted of 10 NCSalone trials. As in Experiments 1A and 1B, conditioning consisted of 30 tone-shock pairings (240 Ϯ 60-s ITI) across 3 days. The rationale was that the pretraining results-magnitude of R1 area in NCS-alone trials-should be most applicable to Experiment 1A, in which testing was done in a shifted context, whereas the post-conditioning data should be most applicable to Experiment 1B, in which testing was done in the original training context. One day before conditioning, the R1 response was elicited 10 times (30-s ITI) in the chamber to be used for conditioning. Twenty-four hours after the last day of conditioning, the R1 response was elicited another 10 times (30-s ITI) in the same chamber.
Experimental design and statistical analysis. Experiment 2 used a 2 ϫ 10 repeated measures design, with conditioning (before or after CS-US pairings) and trial number (10 trials on each test) as withinsubjects factors. Linear regression and analysis of variance (ANOVA) were used to evaluate the stability of the R1 reflex when elicited using NCS parameters and repetition rates identical to those employed in the first experiment. 
Results
Experiment 1A
Subjects and histology. A total of 43 rats underwent surgery, 28 of which were used for data analysis. Of the 15 rats that were dropped, 6 had improper cannula placements, 8 had unacceptable R1 responses, and 1 died after surgery. The bilateral cannula tracks from each rat were marked onto anatomically matched sections from the atlas of Paxinos and Watson (1998) . All rats included in the data analysis had bilateral cannulas implanted in or just dorsal to BLA. Figure 2A shows the location of injection sites based on a reconstruction of the cannula placements. Figure 2B shows these same sites magnified to illustrate the spatial relationships among the cannula placements and the three subnuclei of BLA. All cannula sites were either in or just dorsal to the LA and BL subnuclei of BLA. Figure 2C shows a photomicrograph of bilateral cannula tracks from a typical rat.
NCS current. There was no significant difference, t(54) ϭ Ϫ1.21, p ϭ .23, between the mean (Ϯ SE) NCS current in Group APV (0.69 Ϯ 0.07 mA) and Group ACSF (0.83 Ϯ 0.09 mA).
R1 area on NCS-alone trials. NCS-alone trials were analyzed to determine whether there were significant baseline differences in R1 areas between groups or across test days. The mean (Ϯ SE) R1 area for Group APV on Test Day 1 was 1,611 Ϯ 338 V ⅐ ms, compared to 2,113 Ϯ 327 V ⅐ ms on Test Day 2. The mean area for Group ACSF was 1,870 Ϯ 364 V ⅐ ms on Test Day 1 and 1,538 Ϯ 285 V ⅐ ms on Test Day 2. Averaging across test days, the mean (Ϯ SE) baseline area for Group APV was 1,862 Ϯ 333 V ⅐ ms, compared to 1,704 Ϯ 325 V ⅐ ms for Group ACSF. ANOVA revealed no significant effect of drug, F(1, 52) ϭ 0.23, p ϭ .63, or test day, F(1, 52) ϭ 0.07, p ϭ .80, and the Drug ϫ Test Day interaction, F(1, 52) ϭ 1.60, p ϭ .21, was also not significant. Single-degree of freedom (Scheffé's) tests performed on all six comparisons revealed no significant differences: Group APV on Test Day 1 (APV/1) versus APV/2 ( p ϭ .76), APV/1 versus ACSF/1 ( p ϭ .96), APV/1 versus ACSF/2 ( p ϭ .99), APV/2 versus ACSF/1 ( p ϭ .96), APV/2 versus ACSF/2 ( p ϭ .68), and ACSF/1 versus ACSF/2 ( p ϭ .92).
R1 facilitation. Figure 3A shows conditional R1 facilitation in Groups ACSF and APV across both days of testing. The mean (Ϯ SE) percent R1 facilitation in Group ACSF on the 1st day of testing (ACSF/1) was 56 Ϯ 19%, comparable to previous findings in uncannulated control rats (Choi et al., 2001b; Lam et al., 1996; Lindquist & Brown, in press ). R1 facilitation was completely blocked in Group APV/1, which averaged only Ϫ5 Ϯ 4%. On the 2nd day of testing, when neither group was infused ( Figure 3A) , Figure 3 . DL-2-amino-5-phosphovaleric acid (APV) effects on the expression of four conditional responses tested in a novel context (n ϭ 28). All rats received basolateral amygdala (BLA) infusions with either APV or artificial cerebral spinal fluid (ACSF) just before the 1st day of testing. None of the rats were infused on the 2nd day of testing. Asterisks denote significant differences ( p Ͻ .05) in comparison with Group APV on Test Day 1. A: BLA infusion with APV completely blocked conditional R1 facilitation, which averaged Ϫ5 Ϯ 4%. Conditional R1 facilitation returned in this group on the 2nd day of testing, when none of the rats were infused. The mean percent R1 facilitation following ACSF infusion was 55 Ϯ 19%, comparable to previous reports in uncannulated control rats (Choi et al., 2001b; Lam et al., 1996) . B: APV infusion attenuated freezing by more than half (40 Ϯ 9%) the level seen in the ACSF-infused rats (84 Ϯ 3%). C: APV-infused rats emitted ultrasonic vocalizations (USVs) less than half as much as the ACSF-infused rats (34 Ϯ 10% vs. 63 Ϯ 7%, respectively). D: APV-infused rats defecated less than half as much as the ACSF-infused rats (0.9 Ϯ 0.4 boli vs. 2.7 Ϯ 0.5 boli, respectively).
Group APV/2 demonstrated robust R1 facilitation (52 Ϯ 13%), comparable to that seen in Group ACSF/1 and greater than that in Group ACSF/2 (33 Ϯ 10%), which was lower after a day of extinction trials. Two-way ANOVA revealed a statistically significant Drug ϫ Test Day interaction, F(1, 52) ϭ 9.75, p Ͻ .01. The interaction appeared to subsume the main effects of drug, F(1, 52) ϭ 2.67, p ϭ .11, and test day, F(1, 52) ϭ 1.70, p ϭ .20, which were not significant. The interaction was further explored by using single-degree of freedom (Scheffé's) tests. There were significant differences between APV/1 and ACSF/1 ( p Ͻ .05) and between APV/1 and APV/2 ( p Ͻ .05). The remaining comparisons were not significant: APV/1 versus ACSF/2 ( p ϭ .24), ACSF/1 versus ACSF/2 ( p ϭ .65), ACSF/1 versus APV/2 ( p ϭ .99), and ACSF/2 and APV/2 ( p ϭ .78).
Freezing. Figure 3B shows the amount of freezing in Groups ACSF and APV across both test sessions. On Test Day 1, Group ACSF exhibited 84 Ϯ 3% freezing, whereas Group APV exhibited about half that amount (40 Ϯ 9%). On Test Day 2, Group ACSF exhibited 78 Ϯ 7% freezing, whereas Group APV showed an increase to 84 Ϯ 6%. Two-way ANOVA revealed a statistically significant Drug ϫ Test Day interaction, F(1, 52) ϭ 16.02, p Ͻ .01, and significant main effects for drug, F(1, 52) ϭ 8.87, p Ͻ .01, and test day, F(1, 52) ϭ 8.93, p Ͻ .01. Scheffé's tests found significant differences between APV/1 and ACSF/1 ( p Ͻ .01), APV/1 and APV/2 ( p Ͻ .01), and APV/1 and ACSF/2 ( p Ͻ .01). There were no significant differences between ACSF/1 and ACSF/2 ( p ϭ .92), ACSF/1 and APV/2 ( p ϭ .99), or ACSF/2 and APV/2 ( p ϭ .92).
USV. Figure 3C shows the amount of 22-kHz USV in Groups ACSF and APV on both test days. On Test Day 1, Group ACSF vocalized 63 Ϯ 7% of the time, compared with 34 Ϯ 10% for Group APV. On Test Day 2, Group ACSF vocalized 46 Ϯ 9%, compared with 53 Ϯ 9% for Group APV. Two-way ANOVA revealed a statistically significant Drug ϫ Test Day interaction, F(1, 52) ϭ 4.59, p Ͻ .05, but no significant effect of drug, F(1, 52) ϭ 1.56, p ϭ .22, or test day, F(1, 52) ϭ 0.02, p ϭ .90. Scheffé's tests revealed no significant group differences: APV/1 versus ACSF/1 ( p ϭ .14), APV/1 versus APV/2 ( p ϭ .47), APV/1 versus ACSF/2 ( p ϭ .81), ACSF/1 versus ACSF/2 ( p ϭ .57), ACSF/1 versus APV/2 ( p ϭ .89), and ACSF/2 versus APV/2 ( p ϭ .94).
Defecation. Figure 3D shows the amount of defecation in Groups ACSF and APV across both test days. On Test Day 1, Group ACSF excreted 2.7 Ϯ 0.5 boli, compared with 0.9 Ϯ 0.3 for Group APV. On Test Day 2, Group ACSF excreted 2.6 Ϯ 0.5 boli, and Group APV excreted 2.4 Ϯ 0.6 boli. Consistent with the other fear CRs, two-way ANOVA revealed a significant Drug ϫ Test Day interaction, F(1, 52) ϭ 4.85, p Ͻ .05. The main effects for drug, F(1, 52) ϭ 1.90, p ϭ .17, and test day, F(1, 52) ϭ 3.71, p ϭ .06, were not significant. Scheffé's tests revealed only one significant difference: APV/1 versus APV/2 ( p Ͻ .05). The following comparisons were not significant: APV/1 versus ACSF/1 ( p ϭ .11), APV/1 versus ACSF/2 ( p ϭ .16), ACSF/1 versus ACSF/2 ( p ϭ .99), ACSF/1 versus APV/2 ( p ϭ .98), and ACSF/2 versus APV/2 ( p ϭ .95).
CR correlation matrix. Four of the six Spearman correlations between the CR pairs were statistically significant (see Table 1 ; n ϭ 28). In descending order, correlations with R1 facilitation were as follows: freezing (r ϭ .62, p Ͻ .01), defecation (r ϭ .36, p Ͻ .05), and USV (r ϭ .35, p Ͻ .05). Overall, the two largest correlations were between freezing and USV (r ϭ .75, p Ͻ .01) and between freezing and R1 facilitation (r ϭ .62, p Ͻ .01).
Experiment 1B
Subjects and histology. A total of 41 rats underwent surgery, of which 26 were used for data analysis. Of the 15 rats that were dropped, 7 had improper cannula placements and 8 had unacceptable R1 responses. All rats included in the data analysis had cannulas implanted bilaterally in or just dorsal to BLA. Figure 4A shows the location of injection sites based on histological reconstructions of cannula placements. The location of the injection sites is magnified in Figure 4B to illustrate placements in relationship to the three subnuclei of BLA. Figure 4C shows a photomicrograph of bilateral cannulas tracks from a typical rat.
NCS current. There was no significant difference, t(50) ϭ Ϫ0.58, p ϭ .56, between the mean current used to elicit an R1 response in Group APV (0.98 Ϯ 0.15 mA) and Group ACSF (1.12 Ϯ 0.19 mA).
NCS-alone trials. The mean (Ϯ SE) baseline area for Group APV on test Day 1 was 1,119 Ϯ 139 V ⅐ ms, compared with 1,445 Ϯ 266 V ⅐ ms on Test Day 2. The mean baseline area for Group ACSF was 1,241 Ϯ 196 V ⅐ ms on Test Day 1 and 1,067 Ϯ 142 V ⅐ ms on Test Day 2. Averaging across test days, the mean baseline area for Group APV was 1,282 Ϯ 203 V ⅐ ms, compared with 1,154 Ϯ 169 V ⅐ ms for Group ACSF. There was no significant effect of drug, F(1, 48) ϭ 0.44, p ϭ .51, or test day, F(1, 48) ϭ 0.15, p ϭ .70, and the Drug ϫ Test Day interaction, F(1, 48) ϭ 1.68, p ϭ .20, was not significant. Single-degree of freedom (Scheffé's) tests revealed no significant differences in any of the six comparisons: APV/1 versus APV/2 ( p ϭ .24), APV/1 versus ACSF/1 ( p ϭ .66), APV/1 versus ACSF/2 ( p ϭ .85), APV/2 versus ACSF/1 ( p ϭ .46), APV/2 versus ACSF/2 ( p ϭ .17), and ACSF/1 versus ACSF/2 ( p ϭ .53).
R1 facilitation. Figure 5A shows conditional R1 facilitation in Groups ACSF and APV on both days of testing. Group ACSF/1 averaged 48 Ϯ 7%, slightly lower than seen in Experiment 1A, in which testing was done in a novel context. Conditional R1 facilitation was blocked in Group APV/1, which averaged only 0.4 Ϯ 7%. On the 2nd day of testing, when neither group was infused ( Figure 5A ), Group APV/2 demonstrated clear R1 facilitation (41 Ϯ 11%), almost as much as Group ACSF/1 and greater than Group ACSF/2 (37 Ϯ 10%), which was lower after a day of testing. Two-way ANOVA revealed a significant Drug ϫ Test Day interaction, F(1, 48) ϭ 8.96, p Ͻ .01. The main effect of drug was significant, F(1, 48) ϭ 5.62, p Ͻ .05, whereas the effect of test day was not, F(1, 48) ϭ 2.34, p ϭ .13. Scheffé's tests found significant group differences between APV/1 and ACSF/1 ( p Ͻ .01), APV/1 and APV/2 ( p Ͻ .01), and APV/1 and ACSF/2 ( p Ͻ .01). There were no significant differences between ACSF/1 and ACSF/2 ( p ϭ .31), ACSF/1 and APV/2 ( p ϭ .55), or ACSF/2 and APV/2 ( p ϭ .66).
Freezing. Figure 5B shows freezing in both groups over the 2 days of testing. On the average, rats in Group ACSF/1 were freezing on almost all of the sample periods (95 Ϯ 2%), compared with less than a third of the time (26 Ϯ 7%) for rats in Group APV/1. On Test Day 2, Group ACSF averaged 92 Ϯ 2% freezing, whereas Group APV averaged 83 Ϯ 4% freezing. A two-way ANOVA revealed a statistically significant Drug Paxinos and Watson (1998) . Numbers to the right of each plate give its anterior-posterior location in millimeters relative to bregma (Ϫ1.80 to Ϫ3.14). Open and filled circles denote the cannulas placements in the artificial cerebral spinal fluid and DL-2-amino-5-phosphovaleric acid groups, respectively. Reprinted from The Rat Brain in Stereotaxic Coordinates, 4th ed., G. Paxinos and C. Watson, Figures 26, 28, 30, 31, and 32, Copyright 1998, with groups APV/1 and ACSF/1 ( p Ͻ .01), APV/1 and APV/2 ( p Ͻ .01), and APV/1 and ACSF/2 ( p Ͻ .01). There were no significant differences between Groups ACSF/1 and ACSF/2 ( p ϭ .98), ACSF/1 and APV/2 ( p ϭ .27), or ACSF/2 and APV/2 ( p ϭ .49).
USV. Figure 5C illustrates the mean (Ϯ SE) percent USV across both test sessions. On Test Day 1, Group ACSF vocalized 73 Ϯ 19% of the time, compared with 19 Ϯ 8% for Group APV. On Test Day 2, Group ACSF vocalized 65 Ϯ 9%, whereas Group APV vocalized 59 Ϯ 9%. A corrupted audio recording for 1 rat on Test Day 2 resulted in the loss of 1 df. Two-way ANOVA revealed a significant Drug ϫ Test Day interaction, F(1, 47) ϭ 8.38, p Ͻ .01. The main effect of drug, F(1, 47) ϭ 13.26, p Ͻ .01, was significant, but the main effect of test day, F(1, 47) ϭ 3.67, p ϭ .06, was not. Scheffé's tests revealed significant group differences for APV/1 versus ACSF/1 ( p Ͻ .01), APV/1 versus APV/2 ( p Ͻ .05), and APV/1 versus ACSF/2 ( p Ͻ .01). There were no significant differences between ACSF/1 and ACSF/2 ( p ϭ .92), ACSF/1 and APV/2 ( p ϭ .69), or ACSF/2 and APV/2 ( p ϭ .96).
Defecation. Figure 5D shows the amount of defecation in both groups as a function of test day. On Test Day 1, Group ACSF excreted 4.1 Ϯ 0.5 boli, compared with 0.8 Ϯ 0.3 for Group APV. On Test Day 2, Group ACSF excreted 2.5 Ϯ 0.5 boli, whereas Group APV excreted 2.8 Ϯ 0.6 boli. Two-way ANOVA revealed a statistically significant Drug ϫ Test Day interaction, F(1, 48) ϭ 13.61, p Ͻ .01. A significant main effect was found for drug, F(1, 48) ϭ 9.29, p Ͻ .01, but not for test day, F(1, 48) ϭ 0.23, p ϭ .63. Scheffé's tests found significant differences between Groups APV/1 and APV/2 ( p Ͻ .05) and APV/1 and ACSF/1 ( p Ͻ .01). The following comparisons were not significant: APV/1 versus ACSF/2 ( p ϭ .12), ACSF/1 versus ACSF/2 ( p ϭ .18), ACSF/1 versus APV/2 ( p ϭ .36), and ACSF/2 versus APV/2 ( p ϭ .98).
CR correlation matrix. All four CRs were positively correlated with each other and all six correlations among them were statistically significant (Table 1 , n ϭ 26). In descending order, correlations with R1 facilitation were as follows: defecation (r ϭ .72, p Ͻ .01), USV (r ϭ .64. p Ͻ .01), and freezing (r ϭ .58, p Ͻ .01). Overall, the two largest correlations were between freezing and defecation (r ϭ .84, p Ͻ .01) and freezing and USV (r ϭ .78, p Ͻ .01).
Experiments 1A and 1B
Comparison of two data sets. Before pooling the data (N ϭ 54; Figures 6 and 7, Table 1 ), the mean values and variances of all four CRs were compared between experiments for both days of testing. Contrasts were Bonferroni-corrected for a family-wise ␣ ϭ .05, Figure 5 . DL-2-amino-5-phosphovaleric acid (APV) effects on the expression of four conditional responses tested in the original conditioning context (n ϭ 26). All rats received basolateral amygdala (BLA) infusions with either APV or artificial cerebral spinal fluid (ACSF) just before the 1st day of testing. None of the rats were infused on the 2nd day of testing. Asterisks denote significant differences ( p Ͻ .05) in comparison with Group APV on Test Day 1. A: BLA infusion with APV completely blocked conditioned R1 facilitation, which averaged 0.4 Ϯ 7.0%. R1 facilitation returned in this group on the 2nd day of testing, when none of the rats were infused. The average amount of R1 facilitation following ACSF infusion was 48 Ϯ 7%, which is comparable to previous reports in uncannulated control rats (Lam et al., 1996; Choi et al., 2001b) . B: APV infusion attenuated freezing by more than two thirds (26 Ϯ 7%) the level seen in the ACSF-infused rats (95 Ϯ 2%). C: APV-infused rats emitted ultrasonic vocalizations (USVs) less than a third as much as the ACSF-infused rats (19 Ϯ 8% vs. 73 Ϯ 7%, respectively). D: APV-infused rats defecated less than a quarter as much as the ACSF-infused rats (0.8 Ϯ 0.3 boli vs. 4.1 Ϯ 0.5 boli, respectively).
requiring (at four contrasts per CR) p Ͻ .0125 for significance. Only 1 of the 16 comparisons of sample means was statistically significant (two-tailed t test for independent samples). On the 1st day of testing, the mean (Ϯ SE) level of freezing in Group ACSF in Experiment 1A (84 Ϯ 3%) was significantly lower than the corresponding level in Experiment 1B (95 Ϯ 2%), t(25) ϭ 2.93, p Ͻ .0125, although the frequency distribution of freezing remained unimodal in the combined groups. An 11% difference in mean levels of freezing in control animals is not unusual between experiments, although the difference could also reflect a context effect. Likewise, only 1 of the 16 tests for homogeneity of variance (Levene test) was statistically significant. On the 1st day of testing, in Experiment 1A the standard deviation of the distribution of conditional R1 facilitation was significantly lower in Group APV (SD ϭ 15%) than the level in the corresponding group of Experiment 1B (SD ϭ 26%), Levene (25) ϭ 9.317, p Ͻ .0125. Neither of these sample differences between experiments was of a nature or size that seemed relevant to inferences from subsequent analysis of the pooled data set, where all four CRs continued to covary in the same pattern as a function of the variables of interest (cf. Figures 3, [5] [6] [7] and Table 1) .
Mean CR levels in pooled data. The mean (Ϯ SE) values for conditional R1 facilitation on Test Day 1 were 52 Ϯ 10% in Group ACSF and Ϫ2 Ϯ 4% in Group APV ( Figure 6A ). On Test Day 2, Group ACSF exhibited 34 Ϯ 7%, whereas Group APV exhibited 46 Ϯ 8%. In Groups ACSF and APV, respectively, freezing ( Figure 6B ) was 89 Ϯ 2% and 33 Ϯ 6% on Test Day 1. On Test Day 2, freezing dropped to 85 Ϯ 4% in Group ACSF and rose to 83 Ϯ 3% in Group APV. Figure 6C reveals that on Test Day 1, rats emitted USVs 68 Ϯ 5% of the time in Group ACSF, but only 26 Ϯ 6% in Group APV. USVs averaged 55 Ϯ 7% on Test Day 2 for Group ACSF, and 56 Ϯ 6% for Group APV. Finally, rats excreted ( Figure 6D ) 3.4 Ϯ 0.4 boli in Group ACSF on Test Day 1, but only 0.9 Ϯ 0.2 boli in Group APV. On Test Day 2, Group ACSF excreted 2.6 Ϯ 0.4 boli, whereas Group APV excreted 2.9 Ϯ 0.4 boli.
In the pooled data set, there was a significant Drug ϫ Test Day interaction for all four CRs: R1 facilitation, F(1, 104) ϭ 18.62, p Ͻ .01; freezing, F(1, 104) ϭ 47.68, p Ͻ .01; USV, F(1, 104) ϭ 12.22, p Ͻ .01; and defecation, F(1, 104) ϭ 16.63, p Ͻ .01. The main effect of drug was also statistically significant for all four CRs: R1 facilitation, F(1, 104) ϭ 7.31, p Ͻ .01; freezing, F(1, 104) ϭ 52.07, p Ͻ .01; USV, F(1, 104) ϭ 11.22, p Ͻ .01; and defecation, F(1, 104) ϭ 9.20, p Ͻ .01. The main effect of test day was statistically significant for freezing, F(1, 104) ϭ 32.93, p Ͻ Figure 6 . DL-2-amino-5-phosphovaleric acid (APV) infusion effects on the expression of four conditional responses in the pooled data set (N ϭ 54). All rats received basolateral (BLA) infusions with either APV or artificial cerebral spinal fluid (ACSF) just before the 1st day of testing. None of the rats were infused on the 2nd day of testing. Asterisks denote significant differences ( p Ͻ .05) in comparison with Group APV on Test Day 1. A: BLA infusion with APV completely blocked conditional R1 facilitation, which averaged Ϫ2 Ϯ 4%. R1 facilitation returned in this group on the 2nd day of testing, when none of the rats were infused. The average amount of R1 facilitation following ACSF infusion was 52 Ϯ 10%, which is comparable to previous reports in uncannulated control rats. (Choi & Brown, 2003; Lam et al., 1996; press) B: APV infusion attenuated freezing by more than half (33 Ϯ 6%) the level in the ACSF-infused rats (89 Ϯ 2%). C: APV-infused rats emitted ultrasonic vocalizations (USVs) less than half as much as the ACSF-infused rats (26 Ϯ 6% vs. 68 Ϯ 5%, respectively). D: APV-infused rats defecated less than a quarter as much as the ACSF-infused rats (0.8 Ϯ 0.2 boli vs. 3.4 Ϯ 0.4 boli, respectively).
.01, but not for conditional R1 facilitation ( p ϭ .053), USV ( p ϭ .18), or defecation ( p ϭ .08).
CR correlation matrix in pooled data. All four CRs were positively correlated with each other, and all six correlations among them were statistically significant (Table 1 , N ϭ 54). In descending order, correlations with R1 facilitation were as follows: freezing (r ϭ .62, p Ͻ .01), defecation (r ϭ .53, p Ͻ .01), and USV (r ϭ .50, p Ͻ .01). Overall, the three largest correlations were between freezing and USV (r ϭ .77, p Ͻ .01), freezing and defecation (r ϭ .70, p Ͻ .01), and freezing and R1 facilitation (r ϭ .62, p Ͻ .01). Conditional R1 facilitation clearly behaves very much like the other CRs across these experimental conditions (Table 1, Figure 6 ).
Discriminant analysis in pooled data. Predictive discriminant analysis performed on rank-order-transformed data was used to assess the relative accuracy with which the four CRs can classify subjects into their correct group (ACSF vs. APV). The classification accuracy, or hit rate, in all four CRs was as follows: R1 facilitation (82%), freezing (91%), USV (69%), and defecation (76%). A composite fear index, consisting of a linear combination of the four CRs, was able to classify 94% of the rats correctly, but this turned out to be no better than a combination of just conditional freezing and R1 facilitation. Freezing alone is impressively predictive of manipulations of BLA function, which also attests to the size and consistency of the APV effect.
Effect of BLA infusion site in pooled data. On the basis of histological reconstruction of the infusion sites, all 54 rats were subdivided into three groups. The LA (n ϭ 28) and BL (n ϭ 10) groups consisted, respectively, of rats with cannulas bilaterally positioned over or in the lateral or basolateral subnuclei of BLA (see Figures 2 and 4) . The third group (mixed, n ϭ 16) was composed of rats that had one cannula in the LA and the other in the BL. None of the rats had cannulas in the basomedial nucleus.
APV had a large effect on all four CRs regardless of the exact locus of the cannulas within BLA (Figure 7) . APV infusion completely blocked conditional R1 facilitation in the LA group (Ϫ0.2%, n ϭ 14), the BL group (Ϫ6%, n ϭ 5), and the mixed group (Ϫ4%, n ϭ 8; Figure 7A ). The individual subgroup means were all close to the overall mean for rats receiving APV infusion (Ϫ2 Ϯ 4%, n ϭ 27). By contrast, the mean value in the ACSFinfused rats (52 Ϯ 10%, n ϭ 27) was similar to previously reported levels in control rats that did not have implanted cannulas (Choi et al., 2001b; Lam et al., 1996; Lindquist & Brown, in press ).
The considerable variability among the three subgroups of control (ACSF-infused) rats appears to reflect the relatively small sample sizes combined with the fact that the distribution of R1 facilitation can be positively skewed (Lindquist & Brown, in press) . Skewedness results from the fact that conditional R1 facilitation has a lower bound (Ϫ100%) but not an upper one, unlike the other three CRs. The unusually large mean and standard error Figure 7 . DL-2-amino-5-phosphovaleric acid (APV) infusion effects on conditional response expression as a function of cannula placement. Rats were pooled from the first two experiments (N ϭ 54) and divided into one of three subgroups based on bilateral cannula placement: LA (both cannulas in the lateral nucleus, n ϭ 28), BL (both cannulas in the basolateral nucleus, n ϭ 10), and mixed (one cannula in LA and one cannula in BL, n ϭ 16). A: APV infusion completely blocked R1 facilitation, regardless of cannula placement. The amount of R1 facilitation, averaged across the three APV-infused subgroups, was Ϫ2 Ϯ 4%. By contrast, R1 facilitation in the ACSF-infused group averaged 52 Ϯ 10%, comparable to that in uncannulated control rats (Choi et al., 2001b; Lam et al., 1996) . There was a significant (* p Ͻ .05) drug effect, but no significant differences among the three subgroups. B: APV infusion reduced freezing by more than half. The drug effect was significant ( p Ͻ .05), but the subgroup effect was not. C: APV infusion reduced 22-kHz ultrasonic vocalization (USV) by more than half. The drug effect was significant ( p Ͻ .05), but the subgroup effect was not. D: APV infusion reduced defecation by more than half. The drug effect was significant ( p Ͻ .05), but the subgroup effect was not.
in Group BL (92 Ϯ 51%), which has the smallest sample size (n ϭ 5), reflects the inclusion of an extreme score. This subject was not rejected as an outlier because its z score, computed on the basis of its cohort of ACSF-infused rats, was less than 3.29 (Tabachnick & Fidell, 2001) . If this rat had been eliminated, the mean (Ϯ SE) level of conditional R1 facilitation in the remainder (42 Ϯ 6%) would be intermediate between the values in the LA and mixed groups ( Figure 7A) . APV infusion diminished freezing by more than half, and there was no hint that this effect might be subnucleus specific ( Figure  7B) . Similarly, APV infusion also diminished USV ( Figure 7C ) and defecation ( Figure 7D ) by more than half, again with no suggestion that the effect is subnucleus specific. ANOVA applied to R1 facilitation revealed a statistically significant main effect of drug, F(1, 48) 
Experiment 2
Subjects and NCS current. Two of the 14 rats that underwent surgery were eliminated as a result of unacceptable R1 responses. The NCS current for each rat was kept constant across both testing sessions. The average (Ϯ SE) NCS current was 0.78 Ϯ 0.11 mA.
R1 stability. Figure 8A shows a time series of averaged R1 responses elicited every 30 s, 1 day before conditioning. The solid line is the linear regression of R1 area on trial number. The curved broken lines are 95% confidence intervals, and the horizontal dashed line has zero slope. The slope of the linear regression (slope ϭ Ϫ8 Ϯ 13 V ⅐ ms/trial, p ϭ .53) was not significantly different from zero. One-way ANOVA revealed no significant effect of trial number, F(1, 9) ϭ 0.33, p ϭ .96. Figure 8B shows comparable results from the same rats after conditioning. Again, the slope (m ϭ 16 Ϯ 21 V ⅐ ms/trial; p ϭ .45) was not significantly different from zero and there was no significant effect of trial number, F(1, 9) ϭ 0.29, p ϭ .98.
Both the mean R1 area and its variability increased after conditioning (cf. Figure 8A and Figure 8B ). The mean R1 baseline area was 1,298 Ϯ 38 V ⅐ ms before conditioning and 1,764 Ϯ 59 V ⅐ ms after conditioning ( Figure 8A and 8B). The coefficient of variation increased from 0.09 before conditioning to 0.11 after conditioning. Repeated measures ANOVA revealed a significant main effect of conditioning, F(1, 110) ϭ 20.33, p Ͻ .01, but not trial number, F(9, 110) ϭ 0.10, p ϭ .99. The Conditioning ϫ Trial Number interaction, F(9, 110) ϭ 0.71, p ϭ .70, was also not significant. If a similar effect can be shown, in a between-subjects comparison with an unconditioned control group (cf. Lam et al., 1996) , then R1 baseline area and R1 facilitation could potentially provide concurrent measures of context and cue conditioning, respectively.
Discussion
In this and previous studies (Choi & Brown, 2003; Lee et al., 2001) , we have identified a cohort of five amygdala-dependent CRs that are all positively correlated with each other and whose expression is consistently blocked or impaired by APV infusion into BLA. These APV-sensitive CRs include conditional R1 facilitation, freezing, USV, defecation, and analgesia. Our working hypothesis is that the shared variances revealed in the CR correlation matrices (Table 1 ; see also Choi & Brown, 2003; Lee et al., 2001; Lindquist & Brown, in press) reflect the fact that the motor centers responsible for these behaviors are all triggered or controlled by output from a common source, the central nucleus of the amygdala, which, in turn, is partly controlled during testing by the strength of conditioning (cf. Choi & Brown, 2003; Choi et al., 2001b; LeDoux, 2000) . The consistent findings from this cohort of amygdala-dependent CRs invites further investigation into any underlying neurophysiological mechanisms that they may share.
In relationship to three of these CRs (conditional freezing, USV, and defecation), there was no hint that the expression of conditional R1 facilitation is uniquely insensitive to disruption by APV infusion into BLA (Figures 6 and 7 , Table 1 ). In brief, the results show that APV infusion completely blocks conditional R1 facilitation and significantly impairs the expression of the other three CRs (Figure 6 ), that this APV effect does not depend on the testing context (Figures 3 and 5) or the exact subnuclear infusion site (Figure 7) , and that the R1 reflex is in fact stable under the conditions of these experiments (Figure 8 ). These claims, along with some behavioral and neurophysiological implications, are elaborated below.
Expression of All Four CRs Is APV Sensitive
In two independent experiments, APV infusion into BLA unequivocally blocked the expression of R1 facilitation ( Figures 3A,  5A & 6A) . APV infusion also greatly attenuated the other three CRs that were simultaneously measured, although the blocking of R1 facilitation was more complete (Figures 3B-D , 5B-D, 6B-D). Discriminant analysis showed that attenuation of R1 facilitation was an excellent predictor of whether a rat was infused with APV, correctly classifying 82% of the 54 rats. There was absolutely no hint in any of the data that conditional R1 facilitation was an outlier or an exception. To the contrary, the overall pattern of results was the same for all four CRs (Figures 3, 5-7; Table 1 ). Across these experimental conditions, conditional R1 facilitation shared 36% of its rank-order variance with freezing, 28% with defecation, and 25% with USV (Table 1 ). The present results, combined with parallel ones by Fendt (2001) , who examined APV infusion effects on the expression of both conditional freezing and acoustic startle facilitation, cause us to reject the hypothesis (Lee et al., 2001 ) that conditional reflex facilitation paradigms produce uniquely APV-insensitive CRs.
Testing Context Does Not Determine APV Effect
APV infusion into BLA inhibited CR expression regardless of whether cue testing occurred in the original conditioning chamber or a novel context (cf. Figures 3 and 5) . In descriptive terms, the most notable context-related effect that we observed, other than the possible increase in R1 baseline area, was that the average power (1 -␤) of the four CRs (Ͼ 0.8 in both experiments) was somewhat higher when testing was done in the original training context.
Different Subnuclear Infusion Sites Give the Same Results
In the pooled data set there was an unmistakably large APV infusion effect on conditional R1 facilitation, and there was no hint that this large effect depended on the exact infusion site within BLA ( Figure 7A ). The same pattern was repeated for the other three CRs (Figure 7, B-D) . The four graphs in Figure 7 convincingly demonstrate that APV blocks or strongly suppresses CR expression and that this effect depends neither on the CR nor on whether the bilateral infusion sites within BLA are both in the LA (n ϭ 14), both in the BL (n ϭ 5), or one is in the LA and the other is in the BL (mixed group, n ϭ 8). Considering that LA and BL are immediately adjacent to each other (Figures 2 and 4) , it would have been surprising if the effective concentration of APV were sufficiently confined spatially to allow such extreme sensitivity to the coordinates of the cannula tips.
Differences Between Two Measures of Reflex Facilitation
Some further insight into the cause of the discrepant APV results might be derivable by comparing the two measures of conditional reflex facilitation, as one, conditional R1 facilitation, consistently covaries with a cohort of other amygdala-dependent CRs and the other is inconsistent in this respect. One hypothesis (Choi et al., 2001a (Choi et al., , 2001b maintains that the differences reflect confounding among uncontrolled variables in the experimental designs used to study APV infusion effects on conditional facilitation of the acoustic startle response. The design issues arise partly from the fact that the acoustic startle response rapidly habituates (Davis, 1972; Davis & Wagner, 1969; Koch, 1999; Leaton et al., 1985) , requiring that APV-infusion effects be studied in rats that have been partially habituated to the startle stimulus just before testing. The concern was that one does not know whether the state of habituation-dishabituation remains constant during testing and following BLA infusion with APV. Design issues also stem from the fact that the startle-inducing stimulus (e.g., ϳ95-120-dB white noise burst) is so aversively loud that this US can support cue conditioning (Leaton & Cranney, 1990) , and possibly therefore also context conditioning, during retention testing. The general concern was that, whereas the retention results are assumed to reflect simple extinction trials, and are interpreted as such, the startle US may also cause cue or context conditioning during testing and/or affect the state of habituation-dishabituation.
Neither of these concerns complicates the interpretation of the present findings on the R1 reflex. The R1 area was shown to be stable under the exact conditions of these experiments (Figure 8 ), supporting the claim ) that this reflex does not habituate or easily fatigue-at least not at the repetition rates used in these experiments (cf. Lindquist & Brown, in press ). The level of NCS current used to study conditional R1 facilitation can be compared to a relatively mild exteroceptive stimulus. The NCS current was too small even to elicit an R2 response reliably, and so few OO motoneurons (described in Faulkner et al., 1997) were discharged that full eyelid closure was elicited in less than half the rats. There is no evidence that this level of NCS is aversive or that it can support fear conditioning. NCS-alone trials never elicit freezing or USV and, in fact, rats will occasionally fall asleep during prolonged testing (unpublished observations). Similarly, transdermal stimulation of the fifth nerve in humans at an intensity that reliably elicits full eyelid closures is reported not to cause pain or discomfort (Dycus & Powers, 2000; Ellrich & Treede, 1998) .
Neurophysiology of CR Acquisition and Expression
In attempting to create a unified neurophysiological understanding of the role of the amygdala in emotional learning and memory, it seems tentatively prudent to identify the discrepant results as outliers that tend to be associated with some, but not all, procedural implementations of the original concept (J. S. Brown et al., 1951) of associative reflex facilitation. The remarkably consistent results obtained from the cohort of APV-sensitive CRs encourages further investigation into the neurophysiological mechanisms that are responsible for their acquisition and expression. The results from this cohort are consistent with other evidence pointing to the importance of NMDAR-associated currents in synaptic signaling and circuit function (Amorapanth, LeDoux, & Nader, 2000; Binns, 1994; Fox, Sato, & Daw, 1990; Li et al., 1995 Li et al., , 1996 Maren & Fanselow, 1995; . One implication is that the consistent finding that APV infusion impairs CR acquisition (Campeau et al., 1992; Fanselow & Kim, 1994; Gewirtz & Davis, 1997; Lee & Kim, 1998; Maren et al., 1996; Miserendino et al., 1990 ) may simply reflect the disruption of normal BLA circuit function. There is, after all, no independent evidence that these APV effects are specifically caused by blocking the induction of NMDAR-dependent associative LTP, which has not yet been shown to be responsible for creating the new CS-CR pathways. Nevertheless, the nearly ubiquitous findings that perturbation of NMDAR function interferes with the acquisition and expression of conditioned fear is also consistent with the hypothesis that the critical memory circuits are located in the amygdala. Surprisingly little is understood about the separate or complementary roles that NMDAR-dependent and NMDAR-independent forms of associative LTP (Bauer et al., 2002; Blair et al., 2001; Teyler, 2000) may play in these and other learning or memory circuits.
Implications of Newer Subunit-Selective NMDAR Antagonists
Studies of subunit-selective NMDAR antagonists may offer additional insights into the function of these receptors. In the amygdala, NMDARs consist of an NR1 subunit conjugated to either an NR2A or NR2B subunit (Monyer, Burnashev, Laurie, Sakmann, & Seeburg, 1994) . The behavioral effects of ifenprodil, which selectively antagonizes the NR1-NR2B complex, are particularly interesting in this regard. A recent study reports that, whereas infusing the amygdala with ifenprodil just prior to conditioning impairs CR acquisition, this same infusion has no effect on CR expression when done just prior to retention testing (Rodrigues, ). This interesting result invites further analysis of the functional roles of NMDAR subunits in synaptic transmission and plasticity in amygdalar synapses (Bauer et al., 2002; Blair et al., 2001; Rodrigues et al., 2001; Szinyei, Stork, & Pape, 2003) . Information about the effects of increasingly more selective NMDAR and Ca 2ϩ -channel antagonists on the induction, maintenance, and expression of associative LTP should help pave the road for parallel explorations into the roles that NMDAR-dependent and NMDAR-independent forms of associative LTP play in creating, maintaining, or enabling specific aspects of emotional learning and memory.
